1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Sweden Pharmaceuticals and Healthcare Report Q3 2016

Sweden Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 92 pages

Includes 3 FREE quarterly updates

BMI View: Pharmaceutical companies will face an increasingly tough drug pricing environment inSweden. The government will expand its use of pharmacoeconomic evaluations in order to provideappropriate justification of current expenditures and future investments in public healthcare, impairing therevenue earning opportunities presented by the growing demand for medicines.Headline Expenditure Projections

- Pharmaceuticals: SEK39.50bn (USD4.68bn) in 2015 to SEK39.67bn (USD4.66bn) in 2016; +0.43% inlocal currency terms and -0.4% in US dollar terms.

- Healthcare: SEK376.25bn (USD44.61bn) in 2015 to SEK386.01bn (USD45.39bn) in2016; +2.6% inlocal currency terms and 1.6% in US dollar terms.

Table Of Contents

Sweden Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Sweden 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sweden 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Sweden 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Sweden 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Sweden 2012-2020) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Sweden 2012-2020) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Sweden 2014-2020) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Sweden 2014-2020) 27
Industry Risk/Reward Index 28
Western Europe Risk/Reward Index 28
Sweden Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Intellectual Property Issues 36
Pricing Regime 37
Reimbursement Regime 38
Market Overview 40
Healthcare Sector 40
Table: Healthcare Resources (Sweden 2010-2015) 43
Table: Healthcare Personnel (Sweden 2010-2015) 43
Table: Healthcare Activity (Sweden 2010-2015) 44
Research and Development 44
Table: Drug Development Member Companies of SwedenBIO, 2015 45
Clinical Trials 46
Epidemiology 48
Competitive Landscape 52
Research-Based Industry 52
Table: Multinational Market Activity 54
Pharmaceutical Distribution 55
Pharmaceutical Retail Sector 56
Company Profile 57
AstraZeneca 57
Meda 62
Medivir 67
Novartis 72
Swedish Orphan Biovitrum (SOBI) 75
Demographic Forecast 81
Table: Population Headline Indicators (Sweden 1990-2025) 82
Table: Key Population Ratios (Sweden 1990-2025) 82
Table: Urban/Rural Population and Life Expectancy (Sweden 1990-2025) 83
Table: Population By Age Group (Sweden 1990-2025) 83
Table: Population By Age Group % (Sweden 1990-2025) 84
Glossary 86
Methodology 88
Pharmaceutical Expenditure Forecast Model 88
Healthcare Expenditure Forecast Model 88
Notes On Methodology 89
Risk/Reward Index Methodology 90
Index Overview 91
Table: Pharmaceutical Risk/Reward Index Indicators 91
Indicator Weightings 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.